Keyphrases
Confidence Interval
90%
Graft-versus-host Disease (GvHD)
88%
Tumor
80%
T Cells
61%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
56%
United States
52%
Smokers
51%
Minnesota
48%
Natural Killer Cells
46%
Hematopoietic Cell Transplantation
42%
Transplantation
39%
Older Adults
37%
Tobacco
37%
Acute Myeloid Leukemia
36%
Breast Cancer
35%
Odds Ratio
35%
Risk Factors
35%
Gene Expression
34%
Hazard Ratio
34%
Clinical Trials
34%
Carcinogen
33%
Obesity
32%
In Cancer
31%
Nicotine
30%
Lung
30%
Atherosclerotic Risk Factors
30%
Overall Survival
30%
COVID-19
30%
Chemotherapy
29%
Prostate Cancer
29%
DNA Adducts
29%
Children's Oncology Group
29%
High Risk
28%
Survivors
27%
Cigarette
26%
CD8+ T Cells
25%
Liver
25%
Mouse Model
25%
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
25%
Unrelated Donor
25%
Metabolism
24%
Apoptosis
23%
Inflammation
23%
Spinocerebellar Ataxia
23%
Leukemia
22%
Lung Cancer
22%
Pediatric
22%
Body Mass Index
22%
Colorectal Cancer
21%
Cancer Cells
20%
Randomized Controlled Trial
20%
Cardiovascular Disease
20%
Smoking Cessation
20%
Meta-analysis
20%
Umbilical Cord Blood
20%
Bone Marrow Transplantation
19%
Quality of Life
19%
Hematopoietic Stem Cell Transplantation
19%
Transcription Factor
19%
Cigarette Smoking
19%
Cardiovascular Risk
19%
Marrow Transplantation
19%
Magnetic Resonance Imaging
19%
African American
19%
Acute Lymphoblastic Leukemia
19%
Bone Marrow
18%
Physical Activity
18%
MicroRNA
18%
B Cells
18%
Single nucleotide Polymorphism
18%
Tumor Cells
18%
Regulatory T Cells
18%
Insulin-like
17%
Immune Response
17%
Genotype
17%
Photosystem II
17%
Growth Factors
17%
Diabetes
17%
Alzheimer's Disease
16%
Childhood Cancer Survivors
16%
Clinical Outcomes
16%
Sleeping Beauty Transposon
16%
Men Who Have Sex with Men
16%
Virus
16%
Treg
16%
Ovarian Cancer
16%
Genome-wide Association Study
16%
Gene Therapy
15%
Childhood Cancer Survivor Study
15%
Placebo
15%
Overexpression
15%
Cotinine
15%
Induced Pluripotent Stem Cells (iPSCs)
15%
Dendritic Cells
15%
Metastasis
15%
Sickle Cell Disease
14%
Nanoparticles
14%
Pediatric Patients
14%
Aging
14%
Stem Cells
14%
Medicine and Dentistry
Diseases
100%
Neoplasm
98%
Malignant Neoplasm
80%
Hematopoietic Cell
68%
Cell Transplantation
51%
Breast Cancer
48%
Pediatrics
41%
Oncology
38%
Cancer
34%
Biological Marker
33%
Childhood Cancer
32%
In Vitro
31%
Overall Survival
31%
Prostate Cancer
31%
Clinical Trial
30%
Acute Myeloid Leukemia
29%
T Cell
29%
Graft Versus Host Reaction
27%
Infection
27%
Hazard Ratio
25%
Cancer Cell
24%
Atherosclerosis
24%
Leukemia
24%
Magnetic Resonance Imaging
23%
Odds Ratio
23%
Quality of Life
22%
Lung
22%
Metastatic Carcinoma
22%
Prevalence
22%
Body Mass Index
21%
COVID-19
21%
Cancer Therapy
20%
Acute Lymphoblastic Leukemia
20%
Cardiovascular Disease
20%
Cord Blood
20%
Health Care Cost
19%
Hematopoietic Stem Cell Transplantation
19%
Radiation Therapy
19%
Ovarian Cancer
19%
Chronic Graft Versus Host Disease
18%
Stem Cell
18%
Diabetes
18%
Cardiovascular System
18%
Gene Expression
17%
Recurrent Disease
17%
Bone Marrow Transplantation
17%
Natural Killer Cell
16%
Receptor
16%
Systematic Review
16%
Immunotherapy
15%
Human Immunodeficiency Virus
15%
Health Care
14%
Randomized Controlled Trial
14%
Melanoma
14%
Carcinogenesis
14%
Cell Therapy
13%
Clinician
13%
Colorectal Carcinoma
13%
Allograft
13%
Wart Virus
13%
Lung Cancer
13%
Cohort Analysis
13%
Cancer Risk
13%
Endothelial Cell
13%
Tumor Progression
12%
Medicine
12%
Logistic Regression Analysis
12%
B Cell
12%
Programmed Cell Death
12%
Biopsy Technique
12%
Congestive Heart Failure
12%
Nicotine Withdrawal
11%
Acute Graft Versus Host Disease
11%
Myelodysplastic Syndrome
11%
Surgeon
11%
Adverse Event
11%
Cohort Effect
11%
Sickle-Cell Disease
11%
Apoplexy
11%
Tumor Cell
11%
Placebo
11%
Hurler Syndrome
11%
Combination Therapy
10%
Pediatrics Patient
10%
Public Health
10%
Cross Sectional Study
10%
Primary Health Care
10%
Comorbidity
10%
Physical Activity
10%
Progression Free Survival
10%
microRNA
10%
Non Small Cell Lung Cancer
10%
Glioblastoma
9%
Maturity Onset Diabetes of the Young
9%
Acute Leukemia
9%
Urinary System
9%
Medicare
9%
Meta-Analysis
9%
Infusion
9%
Arm
9%